CJC-1295 +
Ipamorelin

Combination of a GHRH analog (CJC-1295 no-DAC) and a GHS-R1a agonist (Ipamorelin) — reference tool for in vitro study of the somatotropic axis.

DosagePurity ≥ 99.0% (HPLC)

€84.00per 5 mg + 5 mg vial

QuantityHalloween 2 + 1

3 vials: the cheapest item is free at checkout. Estimate for this product alone; the discount is applied at payment, across your whole cart.

Complete your orderOptional

Limited stock

Shipped within 24 business hours from France, in neutral packaging.

Free shipping from €249. Minimum order €80; delivery options and fees shown on the payment page.

Card, Apple Pay or crypto (USDC, USDT, Bitcoin).

Halloween: 2 + 1 free sitewide · buy 3 items, the cheapest one is free.

Janoshik certificateAnalysis no. 66682, purity Identity confirmed (5.22 + 5.74 mg)Commissioned by: third-party reportView report

A question about this product?

Research Use Only — Laboratory use exclusively. Not intended for veterinary, diagnostic or therapeutic use. No indication for in vivo use. To be handled exclusively by qualified personnel.

Literature

What the literature describes

Studies on Ipamorelin (Raun et al., 1998, PMID 10373343) characterized a selective GHS-R1a receptor agonist inducing pulsatile GH release by pituitary somatotropic cells, without significant elevation of prolactin, ACTH, cortisol, or FSH/LH. CJC-1295 (without DAC) is a stabilized GHRH analog that binds to GHRH-R and amplifies the amplitude of GH pulses. The combination studied in vitro and in preclinical models generates a synergistic effect on GH secretion, with a downstream increase in hepatic IGF-1. Hormonal studies show maintenance of the physiological pulsatile rhythm of GH, unlike direct administration of exogenous GH. Effects reported in the literature include increased lean mass, modulation of lipolysis via adipocyte β-adrenergic signaling, and improved bone turnover markers. These data come from the scientific literature and are provided strictly for informational purposes in a research context. This product is not intended for veterinary, diagnostic or therapeutic use and is not recommended for any use outside a scientific, professional and research setting. [1][2][3]

Research background: Co-formulation of a GHRH analog (CJC-1295 without DAC) and a secretagogue pentapeptide (Ipamorelin) used as a pharmacological tool to characterize joint GHRH-R / GHS-R1a signaling in cell lines.
Reconstitution (lab): Separate reconstitution recommended, using sterile bacteriostatic water. Dilution calculator

Chemical identity

What the vial contains

Reference data for the compound. Measured values appear on the Janoshik certificate, when published.

Research name: CJC-1295 + Ipamorelin
CAS No.: 863288-34-0 / 170851-70-4
Molecular formula: C152H252N44O42 / C38H49N9O5
Molecular weight: 3367.9 / 711.9 g/mol
Specified purity: ≥ 99.0% (HPLC)
Vial content: 5 mg + 5 mg
Storage: Lyophilized: refrigerated (2–8 °C) from receipt, protected from light, or at −20 °C for long-term storage; it tolerates a few days of shipping at room temperature with no expected degradation. Reconstituted: refrigerated (2–8 °C).

Independent analysis

Certificate for 5 mg + 5 mg

Report from Janoshik Analytical, an independent laboratory, for this exact dosage. The data below are taken from the report.

Janoshik certificate for this dosageCommissioned by: third-party report

Purity: Identity confirmed (5.22 + 5.74 mg)
Janoshik task: #66682
Tested: 05/06/2025

View the report All published certificates

Questions

Frequently asked questions

What does a vial of CJC-1295 + Ipamorelin contain?

Each vial contains lyophilised CJC-1295 + Ipamorelin, available in 5 mg + 5 mg. Purity ≥ 99.0% (HPLC), tested by an independent laboratory.

How can I check the purity of CJC-1295 + Ipamorelin?

The Janoshik Analytical (independent laboratory) certificates we hold are shown on this page for the matching dosage and can be verified directly on the laboratory's website. For a dosage without a published certificate, testing is in progress or available on request.

How should CJC-1295 + Ipamorelin be stored?

Lyophilized: refrigerated (2–8 °C) from receipt, protected from light, or at −20 °C for long-term storage; it tolerates a few days of shipping at room temperature with no expected degradation. Reconstituted: refrigerated (2–8 °C).

How is CJC-1295 + Ipamorelin reconstituted in the laboratory?

Separate reconstitution recommended, using sterile bacteriostatic water. The site's dilution calculator helps prepare the desired concentration.

Is CJC-1295 + Ipamorelin intended for human use?

No. CJC-1295 + Ipamorelin is a research reagent (RUO) intended exclusively for in vitro laboratory research. It is not intended for human or veterinary use, nor for diagnosing, preventing or treating any disease.

References